K

Kiniksa Pharmaceuticals Ltd
D

KNSA

20.000
USD
0.32
(1.63%)
مغلق
حجم التداول
16,823
الربح لكل سهم
0
العائد الربحي
-
P/E
-167
حجم السوق
1,444,031,300
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.